health care

Healthcare Fraud & False Claims

Healthcare and life sciences companies and their counsel turn to CRA for investigations and disputes relating to fraud, qui tam and false claims matters, Stark/anti-kickback, and voluntary self-disclosures. We can also serve as an Independent Review Organization or an Independent Monitor. Our industry knowledge and expertise in economics, finance, accounting, and business strategy make us uniquely qualified to assist in all phases of these matters.

We provide consultation and expert testimony in fraud and False Claims Act matters involving promotion, marketing, pricing, reimbursement, and distribution policies.  Leveraging our expertise we also evaluate allegations including kickbacks leading to medically inappropriate provision of goods and services, inappropriate referrals, up-coding, unbundling, deceptive marketing, promotion of drugs for off-label uses not approved by the FDA, fraudulent billing practices, or retention of overpayments.


  • 01
    Complex multi-million-dollar billing dispute for large insurance plan provider
    CRA was retained by counsel representing a large insurance plan provider to help resolve a complex multi-million-dollar billing dispute, between their client...
    View engagement
  • 02
    FCPA investigation at a medical device company
    CRA was engaged by a medical device company that needed to investigate allegations of bribery in India. The company was in the process of selling its Indian...
    View engagement
  • 03
    Investigation of Medicare claims payment processor
    Members of CRA’s team were hired to investigate a payment processor of Medicare claims related to home health aides in approximately 27 states. The team was...
    View engagement

Subscribe to receive our latest Insights.